Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age

Last updated: July 1, 2021
Sponsor: Usama Azhar
Overall Status: Active - Recruiting

Phase

4

Condition

Acute Rhinitis

Allergies & Asthma

Common Cold

Treatment

N/A

Clinical Study ID

NCT04957927
747/RC/KEMU
  • Ages 2-5
  • All Genders

Study Summary

To determine the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age:02 to 05 Years of Age
  • both genders will be included.
  • patients diagnosed with allergic rhinitis.

Exclusion

Exclusion Criteria:

  • patients older than 05 years of age
  • a positive history of HIV,TB,Immune deficiency.
  • any nasal structural abnormality i.e.polyps,deviated nasal septum.
  • history of frequent nasal bleeding,epistaxis.
  • concomitant asthma.

Study Design

Total Participants: 60
Study Start date:
December 12, 2020
Estimated Completion Date:
December 12, 2021

Study Description

Our study will compare the Effectiveness of Montelukast Versus Intranasal Fluticasone Propionate in the Management of Allergic Rhinitis Among Children 02 to 05 Years of Age as in our population compliance with oral medication is better among patients, and is socially and culturally more acceptable.

Connect with a study center

  • King Edward Medical University/Mayo hospital lahore,punjab,pakistan 54000

    Lahore, Punjab 54000
    Pakistan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.